- Home
- GOSS vs HLLY Comparison
GOSS vs HLLY Comparison
Compare GOSS & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- HLLY
- Stock Information
- Founded
- GOSS 2015
- HLLY 1903
- Country
- GOSS United States
- HLLY United States
- Employees
- GOSS N/A
- HLLY N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- HLLY Auto Parts:O.E.M.
- Sector
- GOSS Health Care
- HLLY Consumer Discretionary
- Exchange
- GOSS Nasdaq
- HLLY Nasdaq
- Market Cap
- GOSS 347.8M
- HLLY 437.4M
- IPO Year
- GOSS 2019
- HLLY N/A
- Fundamental
- Price
- GOSS $2.47
- HLLY $4.07
- Analyst Decision
- GOSS Strong Buy
- HLLY Strong Buy
- Analyst Count
- GOSS 4
- HLLY 6
- Target Price
- GOSS $8.50
- HLLY $5.13
- AVG Volume (30 Days)
- GOSS 3.1M
- HLLY 871.4K
- Earning Date
- GOSS 08-05-2025
- HLLY 08-06-2025
- Dividend Yield
- GOSS N/A
- HLLY N/A
- EPS Growth
- GOSS N/A
- HLLY N/A
- EPS
- GOSS N/A
- HLLY N/A
- Revenue
- GOSS $40,237,000.00
- HLLY $593,797,000.00
- Revenue This Year
- GOSS N/A
- HLLY $0.19
- Revenue Next Year
- GOSS $30.65
- HLLY $5.09
- P/E Ratio
- GOSS N/A
- HLLY N/A
- Revenue Growth
- GOSS N/A
- HLLY N/A
- 52 Week Low
- GOSS $0.66
- HLLY $1.60
- 52 Week High
- GOSS $2.65
- HLLY $4.10
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- HLLY 79.82
- Support Level
- GOSS $2.38
- HLLY $3.58
- Resistance Level
- GOSS $2.65
- HLLY $3.91
- Average True Range (ATR)
- GOSS 0.15
- HLLY 0.16
- MACD
- GOSS 0.03
- HLLY 0.03
- Stochastic Oscillator
- GOSS 76.67
- HLLY 96.32
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About HLLY Holley Inc.
Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.